Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00830310 · ClinicalTrials.gov registry record · NA

Customized Medication Adherence Enhancement for Adults With Bipolar Disorder

A NA study of Bipolar Disorder, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
NA
Development phase
43
Enrollment target
1
Study location

NCT00830310 is a NA study of Bipolar Disorder that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 43 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00830310, a NA study of Bipolar Disorder, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

This study is a modular intervention that is intended to improve treatment adherence among individuals with bipolar disorder on atypical antipsychotic therapy who have been identified as having treatment adherence problems.

Conditions Studied

Interventions

  • BEHAVIORAL Psychoeducation module
  • BEHAVIORAL Substance use module
  • BEHAVIORAL Improved communication/rapport with provider module
  • BEHAVIORAL Medication routines management module

Study Locations (1)

Ohio

  • University Hospitals Case Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2009-01
Est. Completion 2010-10
Phase NA

What the Registry Record Tells You About NCT00830310

The ClinicalTrials.gov registry entry for NCT00830310 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (87% lower). The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 4 interventions - of which Psychoeducation module is the first listed.

NCT00830310 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00830310 about?

NCT00830310 is a clinical study titled "Customized Medication Adherence Enhancement for Adults With Bipolar Disorder". This study is a modular intervention that is intended to improve treatment adherence among individuals with bipolar disorder on atypical antipsychotic therapy who have been identified as having treatment adherence problems.

What is the current status of trial NCT00830310?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2009-01. Estimated completion is 2010-10.

What conditions does trial NCT00830310 study?

This clinical trial studies the following conditions: Bipolar Disorder.

What interventions are being tested in trial NCT00830310?

The interventions under investigation include: Psychoeducation module (BEHAVIORAL), Substance use module (BEHAVIORAL), Improved communication/rapport with provider module (BEHAVIORAL), Medication routines management module (BEHAVIORAL).

Who is sponsoring clinical trial NCT00830310?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00830310 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.